Everest Medicines Ltd (1952.HK)
Company Info
| ISIN | KYG3224E1061 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | HK$3.59B |
|---|---|
| EPS | HK$0.00 |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue (TTM) | HK$12.79M |
| Gross Profit (TTM) | HK$31.00K |
| EBITDA (TTM) | -HK$1.39B |
| Year Range | HK$5.98 - HK$30.00 |
| Target Price | HK$24.43 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of HK$10,000 in Everest Medicines Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Everest Medicines Ltd had a return of -32.45% year-to-date (YTD) and -41.74% in the last 12 months. Over the past 10 years, Everest Medicines Ltd had an annualized return of -50.97%, while the S&P 500 had an annualized return of 5.88%, indicating that Everest Medicines Ltd did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -17.44% | -0.59% |
| Year-To-Date | -32.45% | 7.47% |
| 6 months | 17.52% | 4.51% |
| 1 year | -41.74% | -4.20% |
| 5 years (annualized) | -50.97% | 5.88% |
| 10 years (annualized) | -50.97% | 5.88% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 43.84% | -32.00% | -9.18% | -7.90% | ||||||||
| 2022 | -17.60% | 85.44% | 51.66% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Everest Medicines Ltd (1952.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
1952.HK Everest Medicines Ltd | -0.52 | ||||
^GSPC S&P 500 | 0.27 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Everest Medicines Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Everest Medicines Ltd is 93.89%, recorded on Oct 24, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.89% | Feb 17, 2021 | 416 | Oct 24, 2022 | — | — | — |
| -24.89% | Oct 14, 2020 | 12 | Oct 30, 2020 | 50 | Jan 12, 2021 | 62 |
| -16.6% | Jan 26, 2021 | 4 | Jan 29, 2021 | 10 | Feb 16, 2021 | 14 |
| -4.31% | Jan 13, 2021 | 1 | Jan 13, 2021 | 1 | Jan 14, 2021 | 2 |
| -3.41% | Jan 18, 2021 | 1 | Jan 18, 2021 | 2 | Jan 20, 2021 | 3 |
Volatility Chart
The current Everest Medicines Ltd volatility is 16.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.